Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 12;113(9):3097–3109. doi: 10.1111/cas.15398

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

KRAS mutation rates by clinical and pathological parameters in a multi‐institutional cohort of patients with resected pancreatic cancer. (A) Institutional cohort. (B) Year of diagnosis (corresponding to the age of tissue blocks). (C) Tumor cellularity. (D) Tumor size. (E) Receipt of neoadjuvant chemotherapy. (F) Formalin concentration. Dotted lines indicate the overall KRAS mutation rate in the total study group. JFCR, Japanese Foundation for Cancer Research; KU, Keio University; UT, The University of Tokyo